Indian Pacing Electrophysiol. J.
Indian Pacing Electrophysiol. J. 2009;
Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
Download PDF 197 KBHamid Barakpour, MD, Zahra Emkanjoo, MD, Abolfath Alizadeh, MD,Mohammad Ali Sadr-Ameli, MD.
Department of Pacemaker and Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran.
Key Words: Implantable defibrillator; myopotential oversensing; Inappropriate shockAddress for correspondence: Zahra Emkanjoo, MD, Department of Pacemaker and Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Vali-e-Asr Avenue, Tehran 1996911151 Iran. E-mail: Zahra.emkanjoo/at/gmail.com
The clinical efficacy of ICD-CRT therapy depends on accurate sensing of intracardiac signals and sensing algorithms. We report the occurrence of sensing abnormality in a patient with ICD-CRT. In this patient, oversensing of myopotentials during strenuous muscular activity resulted in an inappropriate ICD-CRT discharge. Although modern ICDs are highly effective in detecting and terminating malignant tachyarrhythmias, their detection specificity must be improved. It is possible to find the mechanism of arrhythmia by EGM. Simple device reprogramming make it possible to avoid the oversensing of myopotentials.
Inappropriate therapy (IT) for rhythm other than ventricular fibrillation (VF) and sustained ventricular tachycardia (VT) is the most common adverse event associated with implantable cardioverter defibrillators (ICDs). It occurs in 14-29% of patients, accounting for up to 50% of the total complications1,2. Most of the ITs are due to supraventricular tachycardia (SVT), such as paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF), and sinus tachycardia3. Other mechanisms are reconfirmation error due to a premature ventricular complex following a non-sustained ventricular tachycardia (NSVT), myopotential oversensing, T wave oversensing, lead fracture, device malfunction, electromagnetic interference, and far-field R wave oversensing4,5.
This is the report of a rare case that myopotential oversensing was the cause of inappropriate therapy by an intact lead system of ICD-CRT.
The patient was a 50 - year-old male with a history of coronary artery disease and previous myocardial infarction, with severe depression of left ventricular function and NYHA functional class III, who suffered from recurrent symptomatic ventricular tachycardia (VT). He had an ICD-CRT (Medtronic, InSync Marquis, model# 7277) implanted 3 years ago. A Medtronic lead (model # 6944) was placed in the right ventricular apex, another one (model # 5076) in the right atrium and the third one (model #4193) in the lateral branch of the coronary sinus. ICD detection and
treatment were programmed for three zones, ventricular fibrillation (VF) zone [320 ms, number of intervals detected (NID 9/12)], fast VT zone (via VF, 290 ms), VT zone (400 ms, NID 12/24). Antitachycardia pacing was programmed on. The sensed R wave amplitude was measured at 14 mV and the pacing threshold was 0.3 V and 0.9 V at 0.5 ms in the RV and the LV channels, respectively. During 3 years follow up after ICD implantation, the patient was followed regularly and had no episode of ventricular tachyarrhythmias or any discharge. No change in leads impedance was measured at different positions and no fracture or dislodgement was observed on chest radiographs.
The patient presented to the pacemaker clinic, complaining of a single shock without any warning symptom. The patient received the shock while throwing a metallic object forcefully with strong muscular contraction. No further shock was felt subsequently.
Twenty days later, the patient presented for regular follow up at the ICD clinic. Upon interrogation of the device, the counters revealed one episode of VF, for which a 29.7 J shock was delivered at the time of mentioned event (Figure 1). EGM revealed regular appearance of R-waves at an interval of about 610 ms; however there was undulating high frequency noise distorting the baseline corresponding to the time of forceful muscular contractions (Figure 2). This noise disappeared after delivery of the shock. The device interpreted (detect) this episode as VF, resulting in capacitor charging for VF therapy (charge). To determine the mechanism of electrical signal oversensing, we replicated brief noise by asking the patient to make a sudden strong forward movement against resistance. Impedance of the high voltage lead was within the normal range (50 Ohm) and the episode lasted for 9 seconds. Further interrogation of the defibrillator did not reveal any detrimental alteration in the pacing/ICD leads or the ICD circuit. To avoid inappropriate shock, we programmed longer duration of detection in the VF zone. No recurrence was observed during follow-up with the newly programmed parameters.
This is a typical example of myopotential oversensing. Inappropriate therapy for rhythm other than ventricular fibrillation (VF) and sustained ventricular tachycardia (VT) is the most common adverse event associated with ICD implantation6,7. In the absence of damage to leads, electrical interference with ICD devices has rarely been identified as a cause of inappropriate therapy8. There are some reports about myopotential and / or diaphragmatic oversensing in pacemaker9-13. This is the report of a rare case with ICD-CRT and intact lead system. Babuty et al reported inappropriate ICD discharge secondary to sensed myopotentials during deep breathing or the Valsalva maneuver and other situations without lead failure12. Oversensing of diaphragmatic myopotentials was primarily observed in patients implanted with defibrillator leads providing "integrated bipolar" sensing14,15 In experience of Schulte et al in 90% of cases the reduction of maximum sensitivity was effective in preventing further episodes of nonadequate arrhythmia detection14. Therefore by recording intracardiac electrogram it was possible to demonstrate that the mechanism was an oversensing of the activity of the pectoralis muscles, because the small amplitude of the muscular potentials was detected by the ICD device as VF. The problem can be solved by changing the sensitivity of the device or prolonging the time of detection of ventricular fibrillation to avoid inappropriate shock.
1. Nuain SO, Roelke M, Trouton T, Osswald S, et al. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 1995; 91:2204-2213.
2. Nanthakumar K, Paquette M, Newmann D, Deno DC, et al. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. Am Heart J 2000; 139: 797-803.
Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993; 87:1880-1888.
4. Goldberger JJ, Horvath G, Challapalli R, et al. Inappropriate implantable cardioverter-defibrillator therapy due to detection of premature ventricular complexes. Pacing Clin Electrophysiol 1999; 22: 825-828.
Washizuka T, Chinushi M, Kassai H, et al. Inappropriate discharges from an intravenous implantable cardioverter-defibrillator due to T-wave oversensing. Jpn Circ J 2001; 65: 685-687.
6. Laurent MH, Laurence DS, et al. Effect of a taser shot to the chest of a patient with an implantable defibrillator. Heart Rhythm 2006; 3: 339-341.
7. Al Khadra AS, Abdulaziz AJ, Salem AS. Detection of refrigerator associated 60 Hz alternating current as ventricular fibrillation by an implantable cardioverter-defibrillator. Europace 2006; 8: 175-7.
Mathew P, Lewis C, Neglia J, et al. Interaction between electronic article surveillance systems and implantable defibrillators: insights from a fourth generation ICD. PACE 1997; 20: 2857-2859
9. Deshmukh P, Anderson K. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: two case reports. J Cardiovasc Electrophysiol.1998; 9:767-72.
Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Interv Card Electrophysiol. 1998; 2:367-70.
11. Saeed M, Jin A, Pontone G, Higgins S, Gold M, Harari D, Nunley S,Link MS, Homoud MK, Estes NA , Wang PJ; Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators. Ann Noninvasive Electrocardiol. 2003;8:219-26.
12. Babuty D, Fauchier L, Cosnay P. Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphragmatic muscle. Heart. 1999;81:94-6.
Strohmer B, Schernthaner C, Pichler M. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy. Int J Cardiol. 2005; 102:363-6
14. Schulte B, Sperzel J, Carlsson J, Dursch M, Erdogan A, Pitschner HF. Inappropriate arrhythmia detection in implantable defibrillator therapy due to oversensing of diaphragmatic myopotentials. J Interv Card Electrophysiol. 2001; 5:487-93.
Sree K, Roym J. Inappropriate Sensing of Pectoral Myopotentials by an Implantable Cardioverter Defibrillator System. Pacing and Clinical Electrophysiology, 2004; 27 : 688.